Bertok T, Jane E, Hires M, Tkac J
Cancers (Basel). 2024; 16(22).
PMID: 39594740
PMC: 11592093.
DOI: 10.3390/cancers16223786.
Pinto D, Parameswaran R
Cancers (Basel). 2023; 15(13).
PMID: 37444377
PMC: 10340074.
DOI: 10.3390/cancers15133266.
Yue S, Wang X, Ge W, Li J, Yang C, Zhou Z
ACS Omega. 2023; 8(22):19223-19236.
PMID: 37305274
PMC: 10249083.
DOI: 10.1021/acsomega.3c01653.
Montero-Calle A, Lopez-Janeiro A, Mendes M, Perez-Hernandez D, Echevarria I, Ruz-Caracuel I
Cell Oncol (Dordr). 2023; 46(3):697-715.
PMID: 36745330
PMC: 10205863.
DOI: 10.1007/s13402-023-00778-w.
Zhang Y, Sun L, Lei C, Li W, Han J, Zhang J
Cells. 2022; 11(22).
PMID: 36429094
PMC: 9688771.
DOI: 10.3390/cells11223666.
Loci and motifs of the GalNAcα1 → 3/O related glycotopes in the mammalian glycoconjugates and their lectin recognition roles.
Wu A
Glycoconj J. 2022; 39(5):633-651.
PMID: 35962217
DOI: 10.1007/s10719-022-10068-6.
Glycosylation in cancer: its application as a biomarker and recent advances of analytical techniques.
Haga Y, Ueda K
Glycoconj J. 2022; 39(2):303-313.
PMID: 35156159
DOI: 10.1007/s10719-022-10043-1.
Glycosylation Changes in Prostate Cancer Progression.
Butler W, Huang J
Front Oncol. 2022; 11:809170.
PMID: 35004332
PMC: 8739790.
DOI: 10.3389/fonc.2021.809170.
A conserved major facilitator superfamily member orchestrates a subset of O-glycosylation to aid macrophage tissue invasion.
Valoskova K, Biebl J, Roblek M, Emtenani S, Gyoergy A, Misova M
Elife. 2019; 8.
PMID: 30910009
PMC: 6435326.
DOI: 10.7554/eLife.41801.
Factors Affecting Anti-Glycan IgG and IgM Repertoires in Human Serum.
Muthana S, Gildersleeve J
Sci Rep. 2016; 6:19509.
PMID: 26781493
PMC: 4726023.
DOI: 10.1038/srep19509.
Simple sugars to complex disease--mucin-type O-glycans in cancer.
Kudelka M, Ju T, Heimburg-Molinaro J, Cummings R
Adv Cancer Res. 2015; 126:53-135.
PMID: 25727146
PMC: 5812724.
DOI: 10.1016/bs.acr.2014.11.002.
Protein glycosylation in cancer.
Stowell S, Ju T, Cummings R
Annu Rev Pathol. 2015; 10:473-510.
PMID: 25621663
PMC: 4396820.
DOI: 10.1146/annurev-pathol-012414-040438.
Tumor-associated glycans and their role in gynecological cancers: accelerating translational research by novel high-throughput approaches.
Pochechueva T, Jacob F, Fedier A, Heinzelmann-Schwarz V
Metabolites. 2014; 2(4):913-39.
PMID: 24957768
PMC: 3901231.
DOI: 10.3390/metabo2040913.
The Cosmc connection to the Tn antigen in cancer.
Ju T, Aryal R, Kudelka M, Wang Y, Cummings R
Cancer Biomark. 2014; 14(1):63-81.
PMID: 24643043
PMC: 5808877.
DOI: 10.3233/CBM-130375.
What makes cancer stem cell markers different?.
Karsten U, Goletz S
Springerplus. 2013; 2(1):301.
PMID: 23888272
PMC: 3710573.
DOI: 10.1186/2193-1801-2-301.
The Tn antigen-structural simplicity and biological complexity.
Ju T, Otto V, Cummings R
Angew Chem Int Ed Engl. 2011; 50(8):1770-91.
PMID: 21259410
PMC: 7159538.
DOI: 10.1002/anie.201002313.
Carbohydrate antigens in nipple aspirate fluid predict the presence of atypia and cancer in women requiring diagnostic breast biopsy.
Deutscher S, Dickerson M, Gui G, Newton J, Holm J, Vogeltanz-Holm N
BMC Cancer. 2010; 10:519.
PMID: 20920311
PMC: 2958935.
DOI: 10.1186/1471-2407-10-519.
Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen.
Heimburg-Molinaro J, Almogren A, Morey S, Glinskii O, Roy R, Wilding G
Neoplasia. 2009; 11(8):780-92.
PMID: 19649208
PMC: 2713588.
DOI: 10.1593/neo.09504.
Resolving conflicting data on expression of the Tn antigen and implications for clinical trials with cancer vaccines.
Li Q, Anver M, Butcher D, Gildersleeve J
Mol Cancer Ther. 2009; 8(4):971-9.
PMID: 19372570
PMC: 2752371.
DOI: 10.1158/1535-7163.MCT-08-0934.
Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11.
Heimburg J, Yan J, Morey S, Glinskii O, Huxley V, Wild L
Neoplasia. 2006; 8(11):939-48.
PMID: 17132226
PMC: 1716011.
DOI: 10.1593/neo.06493.